The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
921 FURASIX 40 FUROSEMIDE 40MG TABLET BLISTERPACK HYPERTENSION, DIURETIC ALL FROMS OF OEDEMA. NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 05 L 0287/98 28-JUL-2022 27-JUL-2025 View
922 FUROSIX FUROSEMIDE 20MG/2ML INJECTION AMPOULES DIURETIC, HYPERTENSION ALL FORMS OF OEDEMA NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 10 L 0311/98 29-AUG-2023 28-AUG-2026 View
923 GAHISTAN Guaifenesine 50 mg, Chlorpheniramine Maleate 1 mg/5 ml SYRUP BOTTLE NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 12 L 0817/19 09-June-2023 08-June-2026 View
924 GASTROMET CIMETIDINE 400 mg TABLET NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 04 L 0265/98 14-NOV-2022 13-NOV-2025 View
925 GELALUSIL ALUMINIUM HYDROXIDE 250 MG, MAGNISIUM TRISILICATE 500 MG TABLET BLISTERPACK ANTACID NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 08 L 0094/93 13-NOV-2024 12-NOV-2029 View
926 GENTAMINE GENTAMICIN 80MG/2ML INJECTION AMPOULES ANTIBACTERIAL NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 10 L 0313/98 26-OCT-2023 25-OCT-2026 View
927 GOLDEN CIRCLE BALM METHYL SALICYLATE 15G, MENTHOL 12G, PEPERMINT OIL (MENTHE) 1G, CINNAMON OIL (CANELLE CEYLAN) 1G, CAMPHOR TABL 15G, EUCALYPTUS OIL 3G, NIAOULI OIL, 1,5G, PETROLATUM q.s.to 100 MG LOTION bottle NULL FACTORY NO.2 FACTORY No.2 LAO PDR CERTIFICATE RELEASED 12 L 0795/19 31-JUL-2023 30-JUL-2026 View
928 HEMOCYNON ETAMSYLATE 250MG INJECTION AMPOULES ANTIGOACULANT NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 12 L 0358/99 06 -SEP-2022 05-SEP-2025 View
929 HEXIDINE CHLORHEXIDINE GLUCONATE 20 % 0.04G/1 ML SOLUTION BOTTLE NULL FACTORY NO.2 FACTORY NO. 2 LAO PDR CERTIFICATE RELEASED 12 L 0796/19 20-JUN-2023 19-JUN-2026 View
930 IXAZOMAKS IXAZOMIB 4 MG CAPSULE BLISTERPACK INCOMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY NULL FACTORY NO.2 FACTORY NO. 2 LAOS CERTIFICATE RELEASED 04 L 1333/25 07-APR-2025 06-APR-2030 View